Closing Thoughts: Key Messages for Clinicians and Patients in the Treatment of HER2+ Breast Cancer

Panelists discuss advice for nurses collaborating with oncologists in treating patients with HER2+ breast cancer, as well as closing messages for patients receiving treatment and clinicians involved in the care of those with advanced HER2+ breast cancer.

EP: 1.Overview of HER2 Breast Cancer

EP: 2.HER2+ Breast Cancer Diagnosis: Insights From Patients and Clinicians

EP: 3.Coordinating Care for HER+ Breast Cancer Patients: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of HER2+ Breast Cancer: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in HER2+ Breast Cancer

EP: 6.Navigating HER2+ Breast Cancer Treatment: A Patient's Journey

EP: 7.Navigating Systemic Therapy Options in HER2+ Breast Cancer

EP: 8.Key Insights from the HER2CLIMB Trial

EP: 9.Key Insights From the DEBBRAH and HER2CLIMB-02 Studies

EP: 10.BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases

EP: 11.Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer

EP: 12.Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

EP: 13.Comprehensive Supportive Care for Metastatic HER2+ Breast Cancer

EP: 14.Patient Perspective: Key Aspects of Supportive Care in the HER2+ Breast Cancer Journey

EP: 15.Future Perspectives in HER2+ Breast Cancer

Now Viewing

EP: 16.Closing Thoughts: Key Messages for Clinicians and Patients in the Treatment of HER2+ Breast Cancer

1. Dr Iyengar asks Odessa Williams: What advice can you share for fellow nurses collaborating with oncologists to manage treat patients with HER2+ breast cancer?
2. Dr Iyengar: In closing, what message can you share for patients receiving treatment for HER2+ breast cancer and clinicians treating advanced HER2+ breast cancer? 

Recent Videos